INGENIA Therapeutics
PrivateLast Round
Series B
Jun 21, 2024
Total Funding Raised
$20.9M
Company Overview
INGENIA Therapeutics operates in Healthcare & Life Sciences and is based in Watertown, Massachusetts. Its latest recorded funding round was a Series B round in June 2024.
INGENIA Therapeutics is a biotechnology company that develops therapeutic antibodies to restore dysfunctional microvessels for application in ophthalmic and systemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INGENIA Therapeutics Comparables
Compare INGENIA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Memento Medicines | 88% | |
| AffaMed Therapeutics | 86% | |
| Ollin Biosciences | 84% |
For institutional investors. Book with your work email.
INGENIA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 21, 2024 | ||||
| VC Round | Jun 21, 2024 | ||||
| Series A | Nov 1, 2022 | ||||
| Seed | Sep 29, 2020 | ||||
| Seed | Sep 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
INGENIA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series A, Seed |
INGENIA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about INGENIA Therapeutics's valuation, stock price, and market status.
Is INGENIA Therapeutics a public or private company?
INGENIA Therapeutics is a private company.
What is the current stock price of INGENIA Therapeutics?
INGENIA Therapeutics is a private company, so its shares have no public market price. Caplight tracks INGENIA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is INGENIA Therapeutics worth (valuation)?
Valuation information for INGENIA Therapeutics is not publicly available.
Can I buy INGENIA Therapeutics stock?
INGENIA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was INGENIA Therapeutics's last funding round?
INGENIA Therapeutics's most recent funding round was Series B on June 21, 2024.
Who are the main investors in INGENIA Therapeutics?
Key investors in INGENIA Therapeutics include InterVest.
Will INGENIA Therapeutics IPO soon?
No public IPO plans have been announced for INGENIA Therapeutics.
How can I track INGENIA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in INGENIA Therapeutics's shares on secondary markets.